AVITHRAPID, the cutting-edge European initiative dedicated to accelerating antiviral research and pandemic preparedness, is proud to announce the launch of AVITHRAPID SEMINARS—a dynamic series of expert-driven discussions uniting regulatory authorities, pharmaceutical industry leaders, European projects, and key stakeholders.
The first closed-door seminar is scheduled for Monday, March 3, 2025, featuring a high-level discussion with HERA (DG SANTE), focusing on pandemic preparedness and antiviral strategies.
Two public sessions will follow in Summer and Autumn 2025, welcoming industry experts, policymakers, and researchers to exchange insights and shape the future of antiviral preparedness.
The press release for the event can be found by clicking here.